Cancer
fromNature
2 days agoIndividualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC - Nature
Individualized neoantigen uridine mRNA-LPX vaccines encode patient-specific cancer mutations to induce robust CD8+ and CD4+ T cell responses against early triple-negative breast cancer.